ASX ANNOUNCEMENT FUNDING AGREEMENTS COVERING UP TO 85% OF INVION’S CLINICAL TRIALS COSTS Highlights: • Multi-Year Funding Programs for Clinical Trials: Point8 Capital Pty Ltd (Point8) and Rockford RDF Pty Ltd ATF the Rockford RDF Unit Trust (Rockford Capital) have respectively signed agreements...
Funding Agreements Cover Up to 85% of Clinical Trials Costs
Filed with ASX ·
6ix is reading this filing.
Earlier from Invion
- Recruitment Conclusion for Ph 1 NMSC Trial & Advance to Ph 2
- Appendix 4C and Quarterly Activities Report - June 2026
- Photosoft Platform Expands to Eye Diseases Via Partnership
- Appendix 4C and Quarterly Activities Report - March 2026
- Skin Cancer Trial Moves to BCC With More Encouraging Signals
Follow Invion into a list and get an email when it puts out news.
Follow Invion